The promoter methylation of short stature homeobox gene two (SHOX2) and RAS association domain family 1, isoform A (RASSF1A) have been identified as diagnostic and prognostic biomarkers for lung cancer (8). This evidence concerns the gene RASSF1 and lung carcinoma.